The risk or severity of adverse effects can be increased when estazolam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when ketamine is combined with prilocaine.


The risk or severity of adverse effects can be increased when estazolam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when ketamine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when halothane is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when malathion is combined with acetylcholine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when ramipril is combined with lisinopril.


The risk or severity of adverse effects can be increased when propofol is combined with Remoxipride.


The risk or severity of adverse effects can be increased when isoflurane is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when ramipril is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when propofol is combined with nisoldipine.


The risk or severity of adverse effects can be increased when citalopram is combined with sulpiride.


The risk or severity of adverse effects can be increased when imipramine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when propofol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with nadolol.


The risk or severity of adverse effects can be increased when isoflurane is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when prazosin is combined with Aliskiren.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when codeine is combined with trazodone.


The risk or severity of adverse effects can be increased when tolazoline is combined with tretinoin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when protriptyline is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when propantheline is combined with morphine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with sulpiride.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Mersalyl.


The risk or severity of adverse effects can be increased when butabarbital is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with clidinium.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with sertraline.


The risk or severity of adverse effects can be increased when thiamylal is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with zopiclone.


The risk or severity of adverse effects can be increased when diflorasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when etizolam is combined with olanzapine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with oxymorphone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with dexamethasone.


The risk or severity of adverse effects can be increased when doxepin is combined with Retigabine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with periciazine.


The risk or severity of adverse effects can be increased when metolazone is combined with nifedipine.


The risk or severity of adverse effects can be increased when metolazone is combined with papaverine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when oxaprozin is combined with antipyrine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when loxapine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with fenoprofen.


The risk or severity of adverse effects can be increased when moclobemide is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when loxapine is combined with flunarizine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with levodopa.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when meclizine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with baclofen.


The risk or severity of adverse effects can be increased when quinapril is combined with penbutolol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with procarbazine.


The risk or severity of adverse effects can be increased when Salsalate is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when brotizolam is combined with Retigabine.


The risk or severity of adverse effects can be increased when halothane is combined with meclizine.


The risk or severity of adverse effects can be increased when alclofenac is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with quinidine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with selegiline.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with ketamine.


The risk or severity of adverse effects can be increased when alclofenac is combined with amcinonide.


The risk or severity of adverse effects can be increased when ketorolac is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Salsalate is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with bromazepam.


The risk or severity of adverse effects can be increased when floctafenine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when floctafenine is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with scopolamine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with tiapride.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when benzocaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when haloprogin is combined with flunarizine.


The risk or severity of adverse effects can be increased when Benidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Riociguat.


The risk or severity of adverse effects can be increased when Aclidinium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with amoxapine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with nortriptyline.


The risk or severity of adverse effects can be increased when brotizolam is combined with baclofen.


The risk or severity of adverse effects can be increased when sertraline is combined with Dothiepin.


The risk or severity of adverse effects can be increased when proparacaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when estazolam is combined with prazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with quazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when estazolam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when trimetrexate is combined with nifedipine.


The risk or severity of adverse effects can be increased when amisulpride is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with nefazodone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with bumetanide.


The risk or severity of adverse effects can be increased when dyclonine is combined with doxepin.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with loteprednol.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Flibanserin.


The risk or severity of adverse effects can be increased when clonidine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when THYMOL is combined with Pregabalin.


The risk or severity of adverse effects can be increased when halothane is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Toloxatone is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Rotigotine is combined with lisinopril.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with fenbufen.


The risk or severity of adverse effects can be increased when dibucaine is combined with imipramine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Articaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with glutethimide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with desoximetasone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Retigabine.


The risk or severity of adverse effects can be increased when sotalol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when enflurane is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when oxazepam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with nortriptyline.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with amoxapine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when clozapine is combined with clidinium.


The risk or severity of adverse effects can be increased when Phenelzine is combined with pimozide.


The risk or severity of adverse effects can be increased when ketamine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ketamine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Rotigotine.


The risk or severity of adverse effects can be increased when enflurane is combined with dyclonine.


The risk or severity of adverse effects can be increased when enflurane is combined with propoxyphene.


The risk or severity of adverse effects can be increased when atenolol is combined with timolol.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when aspirin is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when morphine is combined with Riociguat.


The risk or severity of adverse effects can be increased when Olmesartan is combined with clonidine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with benazepril.


The risk or severity of adverse effects can be increased when quinapril is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with flunarizine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Tixocortol.


The risk or severity of adverse effects can be increased when zopiclone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Tramadol is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with minoxidil.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Articaine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with alclofenac.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when methylene blue is combined with apraclonidine.


The risk or severity of adverse effects can be increased when lisinopril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when bupivacaine is combined with thiopental.


The risk or severity of adverse effects can be increased when celecoxib is combined with medrysone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with doxazosin.


The risk or severity of adverse effects can be increased when aspirin is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when aspirin is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when prilocaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when prilocaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when amobarbital is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Tixocortol is combined with rivastigmine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with clidinium.


The risk or severity of adverse effects can be increased when Tixocortol is combined with physostigmine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when paroxetine is combined with sulpiride.


The risk or severity of adverse effects can be increased when perphenazine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when baclofen is combined with ethotoin.


The risk or severity of adverse effects can be increased when valsartan is combined with nabumetone.


The risk or severity of adverse effects can be increased when meperidine is combined with naratriptan.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when meperidine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when bupivacaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when codeine is combined with moclobemide.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfadiazine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Efonidipine is combined with ropinirole.


The risk or severity of adverse effects can be increased when nitrazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Metipranolol.


The risk or severity of adverse effects can be increased when buspirone is combined with promethazine.


The risk or severity of adverse effects can be increased when chloroquine is combined with suprofen.


The risk or severity of adverse effects can be increased when diazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when prazosin is combined with bumetanide.


The risk or severity of adverse effects can be increased when lomustine is combined with clozapine.


The risk or severity of adverse effects can be increased when benazepril is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when bifonazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when prazosin is combined with quinapril.


The risk or severity of adverse effects can be increased when prazosin is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when IDARUBICIN is combined with leflunomide.


The risk or severity of adverse effects can be increased when clozapine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when ethopropazine is combined with quinidine.


The risk or severity of adverse effects can be increased when alclofenac is combined with haloperidol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with thiothixene.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when amcinonide is combined with galanthamine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when codeine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with clonidine.


The risk or severity of adverse effects can be increased when butamben is combined with zonisamide.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with duloxetine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with alclofenac.


The risk or severity of adverse effects can be increased when butamben is combined with tiagabine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with diflorasone.


The risk or severity of adverse effects can be increased when pergolide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when mesalamine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with 6-Mercaptopurine.


The risk or severity of adverse effects can be increased when alprazolam is combined with oxazepam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with efavirenz.


The risk or severity of adverse effects can be increased when alprazolam is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with donepezil.


The risk or severity of adverse effects can be increased when alprazolam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when quazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when linezolid is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when efavirenz is combined with Iloperidone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with cocaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with thalidomide.


The risk or severity of adverse effects can be increased when pergolide is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with ondansetron.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with thioridazine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when tiagabine is combined with levodopa.


The risk or severity of adverse effects can be increased when Sacubitril is combined with nimodipine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when pergolide is combined with tamoxifen.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with thiopental.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with labetalol.


The risk or severity of adverse effects can be increased when pergolide is combined with losartan.


The risk or severity of adverse effects can be increased when chloroxine is combined with nimesulide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Naftifine.


The risk or severity of adverse effects can be increased when brimonidine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with doxazosin.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with betamethasone.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with zonisamide.


The risk or severity of adverse effects can be increased when sertraline is combined with amoxapine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with tiagabine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when temazepam is combined with pentazocine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when Pirlindole is combined with Salbutamol.


The risk or severity of adverse effects can be increased when isradipine is combined with oxycodone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nimodipine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Agomelatine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when Tramadol is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when reserpine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when lomustine is combined with leflunomide.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with triamterene.


The risk or severity of adverse effects can be increased when clozapine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when quazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when Butoconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with salicylamide.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with oxybutynin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nicardipine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with efavirenz.


The risk or severity of adverse effects can be increased when Perospirone is combined with dantrolene.


The risk or severity of adverse effects can be increased when triflupromazine is combined with butalbital.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with malathion.


The risk or severity of adverse effects can be increased when Olopatadine is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when dexamethasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with promethazine.


The risk or severity of adverse effects can be increased when gabapentin is combined with dibucaine.


The risk or severity of adverse effects can be increased when reserpine is combined with ouabain.


The risk or severity of adverse effects can be increased when Vecuronium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when lithium ion is combined with triprolidine.


The risk or severity of adverse effects can be increased when Melatonin is combined with Iloperidone.


The risk or severity of adverse effects can be increased when lithium ion is combined with methylphenidate.


The risk or severity of adverse effects can be increased when lithium ion is combined with methocarbamol.


The risk or severity of adverse effects can be increased when levorphanol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when loxapine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Tiotropium is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with baclofen.


The risk or severity of adverse effects can be increased when Clevidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with terazosin.


The risk or severity of adverse effects can be increased when butorphanol is combined with risperidone.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Sacubitril.


The risk or severity of adverse effects can be increased when trazodone is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Valganciclovir is combined with abacavir.


The risk or severity of adverse effects can be increased when secobarbital is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with brotizolam.


The risk or severity of adverse effects can be increased when triamterene is combined with acebutolol.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Droxicam.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with nitrendipine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with amisulpride.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Halazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when promazine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with topiramate.


The risk or severity of adverse effects can be increased when carprofen is combined with diflunisal.


The risk or severity of adverse effects can be increased when dantrolene is combined with paroxetine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with periciazine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with tiapride.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when loteprednol is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with triflupromazine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with rapamycin.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when budesonide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when methocarbamol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Propiverine is combined with oxycodone.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when alprazolam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when methadone is combined with Drospirenone.


The risk or severity of adverse effects can be increased when captopril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when sulpiride is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when reserpine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nicergoline is combined with Iloperidone.


The risk or severity of adverse effects can be increased when reserpine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with leflunomide.


The risk or severity of adverse effects can be increased when reserpine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when loratadine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when estazolam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when midazolam is combined with halothane.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with cinnarizine.


The risk or severity of adverse effects can be increased when dapsone is combined with nitrofurantoin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ketorolac.


The risk or severity of adverse effects can be increased when pentamidine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with nabumetone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with diflorasone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when nitric oxide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with tenoxicam.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with quinacrine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with phenindione.


The risk or severity of adverse effects can be increased when duloxetine is combined with amisulpride.


The risk or severity of adverse effects can be increased when phenobarbital is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when furazolidone is combined with reserpine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with halothane.


The risk or severity of adverse effects can be increased when propofol is combined with nadolol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with desipramine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with thiamylal.


The risk or severity of adverse effects can be increased when desoximetasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when lorazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when loteprednol is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with nitrazepam.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with clomipramine.


The risk or severity of adverse effects can be increased when tetracaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when lorazepam is combined with nefazodone.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when thioridazine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when propoxyphene is combined with amoxapine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with estazolam.


The risk or severity of adverse effects can be increased when levorphanol is combined with zotepine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with nortriptyline.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with dyclonine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with propoxyphene.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with prazepam.


The risk or severity of adverse effects can be increased when thiopental is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with doxepin.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when methocarbamol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when Naftifine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Flupentixol is combined with baclofen.


The risk or severity of adverse effects can be increased when alprazolam is combined with imipramine.


The risk or severity of adverse effects can be increased when proparacaine is combined with meclizine.


The risk or severity of adverse effects can be increased when alprazolam is combined with meperidine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with galanthamine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Flupentixol is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with haloperidol.


The risk or severity of adverse effects can be increased when Naftifine is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when pramipexole is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Tixocortol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with trandolapril.


The risk or severity of adverse effects can be increased when LISURIDE is combined with felodipine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with prilocaine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with epirizole.


The risk or severity of adverse effects can be increased when LISURIDE is combined with irbesartan.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with linezolid.


The risk or severity of adverse effects can be increased when minoxidil is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Retigabine.


The risk or severity of adverse effects can be increased when clidinium is combined with sertraline.


The risk or severity of adverse effects can be increased when methysergide is combined with tioconazole.


The risk or severity of adverse effects can be increased when clozapine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when levorphanol is combined with enflurane.


The risk or severity of adverse effects can be increased when tacrolimus is combined with procarbazine.


The risk or severity of adverse effects can be increased when lorazepam is combined with propofol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when nalbuphine is combined with triazolam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with nimesulide.


The risk or severity of adverse effects can be increased when diflunisal is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Remoxipride is combined with thiamylal.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when efavirenz is combined with vigabatrin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with amisulpride.


The risk or severity of adverse effects can be increased when trimipramine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with resveratrol.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when tetracaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nitric oxide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when amphotericin b is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Perospirone is combined with trimipramine.


The risk or severity of adverse effects can be increased when zaleplon is combined with quetiapine.


The risk or severity of adverse effects can be increased when zaleplon is combined with ketamine.


The risk or severity of adverse effects can be increased when butamben is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ATROPINE is combined with tolterodine.


The risk or severity of adverse effects can be increased when procaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with Demecarium.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when benztropine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when irbesartan is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when quetiapine is combined with Riociguat.


The risk or severity of adverse effects can be increased when chlormezanone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with histamine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when terconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when proparacaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when sildenafil is combined with oxycodone.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with sotalol.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Vilazodone.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when ritodrine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with mirtazapine.


The risk or severity of adverse effects can be increased when pentazocine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Nepafenac.


The risk or severity of adverse effects can be increased when dobutamine is combined with nylidrin.


The risk or severity of adverse effects can be increased when butorphanol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Lacidipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with gabapentin.


The risk or severity of adverse effects can be increased when midodrine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with isoproterenol.


The risk or severity of adverse effects can be increased when pramipexole is combined with atenolol.


The risk or severity of adverse effects can be increased when Nebivolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when midodrine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when furosemide is combined with metrizamide.


The risk or severity of adverse effects can be increased when Cangrelor is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with loxapine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with epirizole.


The risk or severity of adverse effects can be increased when fenbufen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when resveratrol is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Escitalopram is combined with zotepine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with dobutamine.


The risk or severity of adverse effects can be increased when hexetidine is combined with gabapentin.


The risk or severity of adverse effects can be increased when paroxetine is combined with procarbazine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Efonidipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when nitrazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Mersalyl.


The risk or severity of adverse effects can be increased when fenbufen is combined with formestane.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with triamcinolone.


The risk or severity of adverse effects can be increased when midazolam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Tolcapone.


The risk or severity of adverse effects can be increased when folinic acid is combined with tegafur.


The risk or severity of adverse effects can be increased when nimesulide is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with acemetacin.


The risk or severity of adverse effects can be increased when Halazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with etizolam.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Isometheptene.


The risk or severity of adverse effects can be increased when METAXALONE is combined with tizanidine.


The risk or severity of adverse effects can be increased when methysergide is combined with Olaparib.


The risk or severity of adverse effects can be increased when trimipramine is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Posaconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when sulindac is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Posaconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when glutethimide is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when trazodone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when trazodone is combined with levodopa.


The risk or severity of adverse effects can be increased when oxycodone is combined with HEROIN.


The risk or severity of adverse effects can be increased when Olmesartan is combined with azelastine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Asenapine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Asenapine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with nisoldipine.


The risk or severity of adverse effects can be increased when procarbazine is combined with mirtazapine.


The risk or severity of adverse effects can be increased when suprofen is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when astemizole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when triprolidine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when imipramine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with rasagiline.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when spironolactone is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Remoxipride.


The risk or severity of adverse effects can be increased when betamethasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Flupentixol.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with levodopa.


The risk or severity of adverse effects can be increased when timolol is combined with bumetanide.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with hydromorphone.


The risk or severity of adverse effects can be increased when codeine is combined with Pirlindole.


The risk or severity of adverse effects can be increased when Pramocaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when pargyline is combined with Salbutamol.


The risk or severity of adverse effects can be increased when Pramocaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with flunarizine.


The risk or severity of adverse effects can be increased when olanzapine is combined with tiapride.


The risk or severity of adverse effects can be increased when oxybutynin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when carboprost trometamol is combined with methylergonovine.


The risk or severity of adverse effects can be increased when bepridil is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with barnidipine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with methyldopa.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Telmisartan.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with apraclonidine.


The risk or severity of adverse effects can be increased when loxapine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when metolazone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when apomorphine is combined with prazosin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with nimesulide.


The risk or severity of adverse effects can be increased when trapidil is combined with aspirin.


The risk or severity of adverse effects can be increased when triprolidine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Deferasirox.


The risk or severity of adverse effects can be increased when naratriptan is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Atazanavir is combined with meperidine.


The risk or severity of adverse effects can be increased when floctafenine is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when desipramine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with prazosin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Lurasidone is combined with amoxapine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when flumethasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when ketoconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with enflurane.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when tolterodine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when floctafenine is combined with medrysone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when tizanidine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with haloperidol.


The risk or severity of adverse effects can be increased when dyclonine is combined with felbamate.


The risk or severity of adverse effects can be increased when resveratrol is combined with prednisone.


The risk or severity of adverse effects can be increased when Naftifine is combined with ketoprofen.


The risk or severity of adverse effects can be increased when resveratrol is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when prilocaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when prilocaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with protriptyline.


The risk or severity of adverse effects can be increased when bepridil is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with cetirizine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with glutethimide.


The risk or severity of adverse effects can be increased when valsartan is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when imipramine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Normethadone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when meperidine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when difluprednate is combined with fleroxacin.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with amisulpride.


The risk or severity of adverse effects can be increased when irbesartan is combined with fosinopril.


The risk or severity of adverse effects can be increased when sumatriptan is combined with triflupromazine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when ketoprofen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Tramadol is combined with propoxyphene.


The risk or severity of adverse effects can be increased when sulpiride is combined with clonidine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when prilocaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when loxapine is combined with desipramine.


The risk or severity of adverse effects can be increased when olanzapine is combined with enflurane.


The risk or severity of adverse effects can be increased when loxapine is combined with thiamylal.


The risk or severity of adverse effects can be increased when brotizolam is combined with tiapride.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with benzocaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with thiothixene.


The risk or severity of adverse effects can be increased when Normethadone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Normethadone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when clonidine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Metixene is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when tacrolimus is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with lomustine.


The risk or severity of adverse effects can be increased when clonidine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when estrone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with ethotoin.


The risk or severity of adverse effects can be increased when indapamide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with codeine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when prilocaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with trandolapril.


The risk or severity of adverse effects can be increased when fexofenadine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when zotepine is combined with baclofen.


The risk or severity of adverse effects can be increased when sevoflurane is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when benztropine is combined with biperiden.


The risk or severity of adverse effects can be increased when dibucaine is combined with doxepin.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when azelastine is combined with medrysone.


The risk or severity of adverse effects can be increased when Droxicam is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when rasagiline is combined with perphenazine.


The risk or severity of adverse effects can be increased when methysergide is combined with Elbasvir.


The risk or severity of adverse effects can be increased when pentazocine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when halothane is combined with felodipine.


The risk or severity of adverse effects can be increased when lidocaine is combined with prilocaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with ethotoin.


The risk or severity of adverse effects can be increased when flurazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when lidocaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when procarbazine is combined with droxidopa.


The risk or severity of adverse effects can be increased when zaleplon is combined with doxepin.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with prilocaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when proparacaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when proparacaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Vilazodone.


The risk or severity of adverse effects can be increased when betaxolol is combined with papaverine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with citalopram.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with doxepin.


The risk or severity of adverse effects can be increased when chloroxine is combined with nicardipine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with suprofen.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with bupivacaine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with ethotoin.


The risk or severity of adverse effects can be increased when maprotiline is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Clobetasone.


The risk or severity of adverse effects can be increased when valsartan is combined with nadolol.


The risk or severity of adverse effects can be increased when moclobemide is combined with brimonidine.


The risk or severity of adverse effects can be increased when butabarbital is combined with imipramine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when bumetanide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when desipramine is combined with terbutaline.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when propofol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Idelalisib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when butabarbital is combined with loratadine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when clorazepate is combined with triazolam.


The risk or severity of adverse effects can be increased when clorazepate is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when cocaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when baclofen is combined with fexofenadine.


The risk or severity of adverse effects can be increased when norepinephrine is combined with nylidrin.


The risk or severity of adverse effects can be increased when Halazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when amoxapine is combined with felbamate.


The risk or severity of adverse effects can be increased when Nepafenac is combined with fluocinonide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when clopidogrel is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Pipamperone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when pergolide is combined with fluoxetine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when methadone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with topiramate.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with rasagiline.


The risk or severity of adverse effects can be increased when proguanil is combined with dapsone.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when captopril is combined with tolmetin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with propranolol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with clotiazepam.


The risk or severity of adverse effects can be increased when butorphanol is combined with nitrazepam.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with clonidine.


The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Difenoxin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with trazodone.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Benidipine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when methyldopa is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Lacidipine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with manidipine.


The risk or severity of adverse effects can be increased when betaxolol is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Retigabine.


The risk or severity of adverse effects can be increased when quinidine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when clomipramine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with bromazepam.


The risk or severity of adverse effects can be increased when chlormezanone is combined with etizolam.


The risk or severity of adverse effects can be increased when estazolam is combined with lidocaine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when sulconazole is combined with felodipine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with dexamethasone.


The risk or severity of adverse effects can be increased when midazolam is combined with enflurane.


The risk or severity of adverse effects can be increased when Sacubitril is combined with nicardipine.


The risk or severity of adverse effects can be increased when haloperidol is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with mequitazine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when trimipramine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with methyldopa.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with triflupromazine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ibuprofen.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when ethopropazine is combined with codeine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with dyclonine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Droxicam.


The risk or severity of adverse effects can be increased when terbutaline is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when ropinirole is combined with minoxidil.


The risk or severity of adverse effects can be increased when prednisone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with bicalutamide.


The risk or severity of adverse effects can be increased when ketoconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when metoclopramide is combined with mirtazapine.


The risk or severity of adverse effects can be increased when procarbazine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when methscopolamine is combined with pentazocine.


The risk or severity of adverse effects can be increased when Etomidate is combined with procaine.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when propofol is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when penbutolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with clomipramine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Asenapine.


The risk or severity of adverse effects can be increased when linezolid is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with methocarbamol.


The risk or severity of adverse effects can be increased when selegiline is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when selegiline is combined with maprotiline.


The risk or severity of adverse effects can be increased when physostigmine is combined with acetylcholine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when selegiline is combined with Salmeterol.


The risk or severity of adverse effects can be increased when quinapril is combined with leflunomide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when perphenazine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when perphenazine is combined with dyclonine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when brotizolam is combined with clonidine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when levallorphan is combined with Naloxegol.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Tramadol.


The risk or severity of adverse effects can be increased when reserpine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when reserpine is combined with furosemide.


The risk or severity of adverse effects can be increased when amantadine is combined with memantine.


The risk or severity of adverse effects can be increased when enflurane is combined with flunarizine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with labetalol.


The risk or severity of adverse effects can be increased when formestane is combined with tubocurarine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with butamben.


The risk or severity of adverse effects can be increased when salicylic acid is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when salicylic acid is combined with prednisone.


The risk or severity of adverse effects can be increased when buspirone is combined with HEROIN.


The risk or severity of adverse effects can be increased when thioridazine is combined with lisinopril.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with desoximetasone.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with dyclonine.


The risk or severity of adverse effects can be increased when bumetanide is combined with doxorubicin.


The risk or severity of adverse effects can be increased when temazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when bumetanide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Cariprazine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Remoxipride.


The risk or severity of adverse effects can be increased when tretinoin is combined with reserpine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when doxazosin is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when valsartan is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when estazolam is combined with thiothixene.


The risk or severity of adverse effects can be increased when efavirenz is combined with duloxetine.


The risk or severity of adverse effects can be increased when estazolam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with clidinium.


The risk or severity of adverse effects can be increased when estazolam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when labetalol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Etomidate.


The risk or severity of adverse effects can be increased when ethopropazine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Perospirone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with meperidine.


The risk or severity of adverse effects can be increased when barnidipine is combined with atenolol.


The risk or severity of adverse effects can be increased when methadone is combined with tiapride.


The risk or severity of adverse effects can be increased when brotizolam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with indapamide.


The risk or severity of adverse effects can be increased when Torasemide is combined with risperidone.


The risk or severity of adverse effects can be increased when estazolam is combined with citalopram.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when mecamylamine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when temazepam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with temazepam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Pregabalin.


The risk or severity of adverse effects can be increased when brotizolam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with tiapride.


The risk or severity of adverse effects can be increased when pentobarbital is combined with clidinium.


The risk or severity of adverse effects can be increased when temazepam is combined with oxazepam.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when meperidine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when quinidine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when meperidine is combined with perphenazine.


The risk or severity of adverse effects can be increased when gabapentin is combined with protriptyline.


The risk or severity of adverse effects can be increased when fexofenadine is combined with promethazine.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when gabapentin is combined with cetirizine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when topiramate is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when barnidipine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with cilazapril.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with potassium ion.


The risk or severity of adverse effects can be increased when oxybutynin is combined with oxymorphone.


The risk or severity of adverse effects can be increased when meperidine is combined with pimozide.


The risk or severity of adverse effects can be increased when meperidine is combined with sertraline.


The risk or severity of adverse effects can be increased when selegiline is combined with Milnacipran.


The risk or severity of adverse effects can be increased when oxymorphone is combined with acetazolamide.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when ketorolac is combined with equilin.


The risk or severity of adverse effects can be increased when trazodone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when baclofen is combined with amoxapine.


The risk or severity of adverse effects can be increased when baclofen is combined with nortriptyline.


The risk or severity of adverse effects can be increased when meclizine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when meclizine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with medrysone.


The risk or severity of adverse effects can be increased when pimozide is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when cabergoline is combined with moclobemide.


The risk or severity of adverse effects can be increased when secobarbital is combined with brotizolam.


The risk or severity of adverse effects can be increased when Tramadol is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when thioridazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with proparacaine.


The risk or severity of adverse effects can be increased when ipratropium is combined with tolterodine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with maprotiline.


The risk or severity of adverse effects can be increased when Rufinamide is combined with buspirone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with oxycodone.


The risk or severity of adverse effects can be increased when Tixocortol is combined with cinoxacin.


The risk or severity of adverse effects can be increased when pentazocine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when lamivudine is combined with Emtricitabine.


The risk or severity of adverse effects can be increased when Artemether is combined with diltiazem.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Milnacipran.


The risk or severity of adverse effects can be increased when terconazole is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when pentazocine is combined with potassium ion.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with amisulpride.


The risk or severity of adverse effects can be increased when furazolidone is combined with metaproterenol.


The risk or severity of adverse effects can be increased when butabarbital is combined with oxymorphone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Tramadol is combined with triamterene.


The risk or severity of adverse effects can be increased when chlortetracycline is combined with Bexarotene.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when dibucaine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with amoxapine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when nicergoline is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when meprobamate is combined with ethotoin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with tiapride.


The risk or severity of adverse effects can be increased when meprobamate is combined with prilocaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when meprobamate is combined with isoflurane.


The risk or severity of adverse effects can be increased when clorazepate is combined with triprolidine.


The risk or severity of adverse effects can be increased when acebutolol is combined with nicotine.


The risk or severity of adverse effects can be increased when acebutolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when clorazepate is combined with methocarbamol.


The risk or severity of adverse effects can be increased when scopolamine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when scopolamine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with protriptyline.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Sacubitril is combined with sevoflurane.


The risk or severity of adverse effects can be increased when chlormezanone is combined with cetirizine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with clozapine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with flunarizine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Aceclofenac.